Abstract:The clinical interpretation of missense variants is critically important in diagnostics due to their potential to cause mild-to-severe effects on phenotype by altering protein structure. Evaluating these variants is essential because they can significantly impact disease outcomes and patient management. Many computational predictors, known as in silico pathogenicity predictors (ISPPs), have been developed to support the assessment of variant pathogenicity. Despite the abundance of these ISPPs, their predictions often lack accuracy and consistency, primarily due to limited data availability and the presence of erroneous data. This inconsistency can lead to false positive or negative results in pathogenicity evaluation, highlighting the need for standardization. The necessity for reliable evaluation methods has driven the development of numerous ISPPs, each attempting to address different aspects of variant interpretation. However, the sheer number of ISPPs and their varied performances make it challenging to achieve consensus in predictions. Therefore, a comprehensive statistical approach to evaluate and integrate these predictors is essential to improve accuracy. Here, we present a comprehensive statistical analysis comparing 52 available ISPPs, which aims to enhance the precision of variant classification. Our work introduces the Variant Analysis with Multiple Pathogenicity Predictors-score (VAMPP-score), a novel statistical framework designed for the assessment of missense variants. The VAMPP-score leverages the best gene-ISPP matches based on ISPP accuracies, providing a combinatorial weighted score that improves missense variant interpretation. We chose to develop a statistical framework rather than creating a new ISPP to capitalize on the strengths of existing predictors and to address their limitations through an integrative approach. This approach not only improves the evaluation of missense variants but also offers a flexible statistical framework designed to identify and utilize the best-performing ISPPs. By enhancing the accuracy of genetic diagnostics, particularly in the reanalysis of rare and undiagnosed cases, our framework aims to improve patient outcomes and advance the field of genetic research.

Analysis of missense variants in the human genome reveals widespread gene-specific clustering and improves prediction of pathogenicity

Leveraging cancer mutation data to predict the pathogenicity of germline missense variants

A comparative medical genomics approach may facilitate the interpretation of rare missense variation

Predicting non-neutral missense mutations and their biochemical consequences using genome-scale homology modeling of human protein complexes

Gene-specific machine learning for pathogenicity prediction of rare BRCA1 and BRCA2 missense variants

A New Era in Missense Variant Analysis: Statistical Insights and the Introduction of VAMPP-Score for Pathogenicity Assessment

The landscape of regional missense mutational intolerance quantified from 125,748 exomes

Discordance between a deep learning model and clinical-grade variant pathogenicity classification in a rare disease cohort

VariPred: Enhancing Pathogenicity Prediction of Missense Variants Using Protein Language Models

Critical assessment of missense variant effect predictors on disease-relevant variant data

REVEL: an Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants

Assessment of Computational Methods for Predicting the Effects of Missense Mutations in Human Cancers.

Proteome-Wide Assessment of Clustering of Missense Variants in Neurodevelopmental Disorders Versus Cancer

The performance of AlphaMissense to identify genes causing disease

Predicting Pathology of Missense Mutations through Protein-Specific Evolutionary Pattern

MVP predicts the pathogenicity of missense variants by deep learning

Decoding molecular mechanisms for loss of function variants in the human proteome

Genetic constraint at single amino acid resolution in protein domains improves missense variant prioritisation and gene discovery

Cross-protein transfer learning substantially improves disease variant prediction

The performance of AlphaMissense to identify genes influencing disease